SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Price regulation and parallel imports of pharmaceuticals
14 references·0 citing·51 second hopsampled
Price regulation and parallel imports of pharmaceuticals (2015)Price regulation and parallel imports of …Equilibrium parallel import policies and international market structure (2012)Equilibrium parallel import p…Cost-Containment Policies in Public Pharmaceutical Spending in the EU (2012)Cost-Containment Policies in …Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Regulation and pricing of pha…Pharmaceutical Price Controls and Entry Strategies (2007)Pharmaceutical Price Controls…PARALLEL TRADE, INTERNATIONAL EXHAUSTION AND INTELLECTUAL PROPERTY RIGHTS: A WELFARE ANALYSIS* (2006)PARALLEL TRADE, INTERNATIONAL…Parallel Imports and Price Controls (2006)Parallel Imports and Price Co…Vertical Pricing and Parallel Imports (2005)Vertical Pricing and Parallel…Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry (2005)Drug Prices and Research and …Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)Parallel imports and the pric…Examining the link between price regulation and pharmaceutical R&D investment (2004)Examining the link between pr…Should the US allow prescription drug reimports from Canada? (2002)Should the US allow prescript…Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)Does Regulation Drive Out Com…Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU (1997)Price Discrimination for Phar…Parallel imports, demand dispersion, and international price discrimination (1994)Parallel imports, demand disp…Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)The Determinants of Mortality (2006)Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)Overview of external reference pricing systems in Europe (2015)The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption (2015)What pricing and reimbursement policies to use for off-patent biologicals in Europe? – results from the second EBE biological medicines policy survey (2017)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Generic Entry and the Pricing of Pharmaceuticals (1997)THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS (2014)Patents and the Global Diffusion of New Drugs (2015)Intellectual Property Rights in the Global Economy (2000)Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents (2003)International Protection of Intellectual Property (2004)Parallel Trade and its Ambiguous Effects on Global Welfare (2012)Parallel trade, product quality, and welfare (2013)Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy (1993)The Regulation of Entry (2000)Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)International Prices And Availability Of Pharmaceuticals In 2005 (2008)How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries (2017)Cost of innovation in the pharmaceutical industry (1991)Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries (2003)Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)Economics of the Pharmaceutical Industry (2018)A Contribution to the Theory of Taxation (1927)A Theory of Incentives in Procurement and Regulation (1993)A theory of incentives in procurement and regulation (1994)The Economics of Parallel Trade (1998)Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (2003)Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues (2018)A ‘reciprocal dumping’ model of international trade (1983)The Theory of Industrial Organization (1988)Theory of Industrial Organization. (1989)The Evolution of Price Dispersion in the European Car Market (2001)Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement (2013)Specification Tests in Econometrics (1978)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry? (2007)Structural changes in the German pharmaceutical market: Price setting mechanisms based on the early benefit evaluation (2013)The impact of regulation on innovation (2016)Capital-Market Imperfections and Investment (1997)The price of innovation: new estimates of drug development costs (2003)Asymmetric Growth and Institutions in an Interdependent World (2017)Public sector financial support for late stage discovery of new drugs in the United States: cohort study (2019)Estimating the Effect of Training Programs on Earnings (1978)Evaluating the Effect of Teachers’ Group Performance Incentives on Pupil Achievement (2002)Reference pricing of pharmaceuticals (2006)Effects of Reference Pricing in Pharmaceutical Markets (2010)Does the Market Share of Generic Medicines Influence the Price Level? (2011)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2007Pharmaceutical Price Controls and Entry Strategies298 cited
  • 1994Parallel imports, demand dispersion, and international price discrimination258 cited
  • 2000Does Regulation Drive Out Competition in Pharmaceutical Markets?237 cited
  • 2004Parallel imports and the pricing of pharmaceutical products: evidence from the European Union205 cited
  • 2012Cost-Containment Policies in Public Pharmaceutical Spending in the EU167 cited
  • 2008Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?153 cited
  • 2005Drug Prices and Research and Development Investment Behavior in the Pharmaceutical Industry149 cited
  • 2004Examining the link between price regulation and pharmaceutical R&D investment145 cited
  • 1997Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU122 cited
  • 2006Parallel Imports and Price Controls104 cited
  • 2002Should the US allow prescription drug reimports from Canada?80 cited
  • 2006PARALLEL TRADE, INTERNATIONAL EXHAUSTION AND INTELLECTUAL PROPERTY RIGHTS: A WELFARE ANALYSIS*77 cited
  • 2005Vertical Pricing and Parallel Imports57 cited
  • 2012Equilibrium parallel import policies and international market structure35 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work